Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation... Show more
Industry Biotechnology
A.I.dvisor tells us that ACHFF and CCCC have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACHFF and CCCC's prices will move in lockstep.
| Ticker / NAME | Correlation To ACHFF | 1D Price Change % | ||
|---|---|---|---|---|
| ACHFF | 100% | +0.83% | ||
| CCCC - ACHFF | 24% Poorly correlated | -8.67% | ||
| AVTX - ACHFF | 23% Poorly correlated | -2.17% | ||
| ACAD - ACHFF | 23% Poorly correlated | -0.23% | ||
| ALDX - ACHFF | 23% Poorly correlated | +4.33% | ||
| EDSA - ACHFF | 22% Poorly correlated | +1.50% | ||
More | ||||